Better decisions faster
With a full scope of services from First in Man through Proof of Concept, PAREXEL Early Phase has a global network of clinical units that test compounds and devices in healthy volunteers and patients, helping our biopharmaceutical clients make valuable decisions quickly and safely.
It's never too early to make smart decisions. PAREXEL Early Phase can help you make better decisions - faster. Our consistent delivery of timely results and high quality data adds value now - and greater value in the long term, providing expertise and advice to help you collect the right data and mitigate risk of Phase III failure.
9 International units – 1 harmonized global team
However you look at our strategic global locations: 9 early phase clinical units, 3 continents, 2 hemispheres, 4 unique regulatory environments; PAREXEL Early Phase offers the unique advantage to our clients that we operate as 1 global team. With harmonized process, global SOPs across our strategic global locations we offer great opportunity to accelerate our clients’ timeline through our global patient reach, multi-site option and global program management, across the full scope of early phase studies in healthy volunteers and patients.
Healthy volunteers and patient populations
PAREXEL Early Phase understand the importance of rapid recruitment solutions in drug development. We have a ready supply of healthy volunteers and diverse patient populations in-house across our global network of 9 clinical units.
